Compare AbCellera Biologics Inc (ABCL) vs Equinor ASA (EQNR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Equinor ASA — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Equinor ASA trades at $40.93 (market cap $97.58B). The key difference: Equinor ASA is far larger — about 32.6× AbCellera Biologics Inc's market cap, and Equinor ASA pays a 3.81% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | EQNR | |
|---|---|---|
Market Cap | $2.99B | $97.58B |
Sector | Health | Energy |
52-Week High | $9.76 | $42.40 |
52-Week Low | $2.78 | $22.41 |
Enterprise Value | $2.58B | $106.28B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →
